title: Expression of P-glycoprotein in the intestinal epithelium of dogs with lymphoplasmacytic enteritis.
abstract: Inflammatory bowel disease (IBD) is an idiopathic chronic inflammatory disease of the stomach, the small intestine and/or the large intestine. Loss of integrity of the intestinal barrier may be an important factor in the pathogenesis of IBD. In dogs, lymphoplasmacytic enteritis (LPE) is one of the recognized forms of IBD. P-glycoprotein (P-gp) is a membrane-bound efflux pump constituting an important component of the intestinal barrier. Changes in P-gp expression at the level of the intestinal barrier may be important in the pathogenesis of canine LPE, as this may lead to variable protection against xenobiotics and bacterial products in the intestine. The aim of the present study was to evaluate the expression of epithelial P-gp in the intestine in dogs with LPE compared with disease-free animals. Formalin-fixed intestinal biopsy samples from 57 dogs with histopathological evidence of LPE were immunolabelled with anti-P-gp antibodies (C494 and C219). Endoscopic biopsy samples of the duodenum and colon from 16 healthy beagles were used as controls. None of the control dogs had P-gp expression in the apical membrane of duodenal enterocytes, but all had P-gp labelling at the colonic epithelial surface. Twenty out of 57 dogs with LPE had P-gp expression at the apical surface membrane of villus epithelial cells in the duodenum, jejunum and/or ileum. Six out of 16 colonic samples from dogs with LPE had decreased P-gp expression at the epithelial surface compared with controls. It is unclear whether these changes in P-gp expression in dogs with LPE are a cause or a consequence of the inflammation. The observed changes could affect bioavailability of therapeutic drugs used in LPE.
authors.affiliation: Department of Pathology, Bacteriology and Poultry Diseases, B-9820 Merelbeke, Belgium. Sara.VanderHeyden@UGent.be
authors.forename: S
authors.initials: S
authors.lastname: Van der Heyden
authors.forename: G
authors.initials: G
authors.lastname: Vercauteren
authors.forename: S
authors.initials: S
authors.lastname: Daminet
authors.forename: D
authors.initials: D
authors.lastname: Paepe
authors.forename: K
authors.initials: K
authors.lastname: Chiers
authors.forename: I
authors.initials: I
authors.lastname: Polis
authors.forename: T
authors.initials: T
authors.lastname: Waelbers
authors.forename: M
authors.initials: M
authors.lastname: Hesta
authors.forename: S
authors.initials: S
authors.lastname: Schauvliege
authors.forename: B
authors.initials: B
authors.lastname: Wegge
authors.forename: R
authors.initials: R
authors.lastname: Ducatelle
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis*; D000818:Animals; D001706:Biopsy; D004283:Dog Diseases / Q000378:metabolism* / Q000473:pathology; D004285:Dogs; D004378:Duodenal Diseases / Q000378:metabolism / Q000473:pathology / Q000662:veterinary; D004751:Enteritis / Q000378:metabolism / Q000473:pathology / Q000662:veterinary*; D007150:Immunohistochemistry; D015212:Inflammatory Bowel Diseases / Q000378:metabolism / Q000473:pathology / Q000662:veterinary; D007413:Intestinal Mucosa / Q000378:metabolism* / Q000473:pathology
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1